Steward Partners Investment Advisory, LLC Cor Medix Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $12.3 Billion
- Q2 2025
A detailed history of Steward Partners Investment Advisory, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 165,562 shares of CRMD stock, worth $1.9 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
165,562
Previous 159,637
3.71%
Holding current value
$1.9 Million
Previous $983,000
107.43%
% of portfolio
0.02%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding CRMD
# of Institutions
179Shares Held
32.1MCall Options Held
873KPut Options Held
597K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.9 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.7 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.4 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $474M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...